SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?


To: John Metcalf who wrote (2200)5/27/1999 4:11:00 AM
From: Walter Morton  Read Replies (1) | Respond to of 2742
 
It seems that Genome Securities is taking all of the credit for what goes well at CIST: genomesecurities.com



To: John Metcalf who wrote (2200)5/27/1999 11:40:00 AM
From: Rudy Saucillo  Read Replies (2) | Respond to of 2742
 
<<The fact that the Board has not appointed an operating officer may suggest that they intend to liquidate, rather than operate the company.>>

I hope so. I really feel this is in the best interest of shareholders at this point in time.

Rudy



To: John Metcalf who wrote (2200)6/1/1999 1:12:00 PM
From: Steve Harmon  Read Replies (2) | Respond to of 2742
 
SALE – MERGER – ACQUISITION
BUSINESS COMBINATION
OPPORTUNITY

(OTC: CIST)

As advertised on the Genome web site.